Advertisement

Ads Placeholder
Loading...

DiaSorin S.p.A.

DSRLF•PNK
Healthcare
Medical - Diagnostics & Research
$67.00
$0.00(0.00%)
U.S. Market opens in 62h 56m

DiaSorin S.p.A. (DSRLF) Stock Overview

Explore DiaSorin S.p.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.6B
P/E Ratio16.67
EPS (TTM)$3.28
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$83.07
3 Months$79.73
1 Year Target$92.35

DSRLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DiaSorin S.p.A. (DSRLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 14.24, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $92.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.67 and a market capitalization of 3.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-17.94%
3-Month Change
-11.89%
6-Month Change
-28.91%
Year-to-Date (YTD) Change
-11.89%
1-Year Change
-38.87%
3-Year Change
-39.82%
5-Year Change
-59.77%
All-Time (Max) Change
258.29%

Contact Information

https://diasoringroup.com
39 01 614871
Via Crescentino snc, Saluggia, VC, 13040

Company Facts

32,490 Employees
IPO DateSep 11, 2009
CountryIT
Actively Trading

Frequently Asked Questions